Detalhe da pesquisa
1.
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
Nature
; 595(7869): 718-723, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082438
2.
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV.
Emerg Microbes Infect
; 12(2): 2275598, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078382
3.
Antibodies as drugs-a Keystone Symposia report.
Ann N Y Acad Sci
; 1519(1): 153-166, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382536
4.
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
BioDrugs
; 36(3): 231-323, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476216
5.
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.
J Immunol
; 183(10): 6338-45, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19841167
6.
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199.
Mol Cancer Ther
; 20(12): 2483-2494, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711645
7.
Structure, Function, and Therapeutic Use of IgM Antibodies.
Antibodies (Basel)
; 9(4)2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066119
8.
Antibody discovery via multiplexed single cell characterization.
J Immunol Methods
; 341(1-2): 135-45, 2009 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19087879
9.
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
J Am Soc Nephrol
; 14(9): 2237-47, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12937299